These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 34775204

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors.
    Sever B, Altıntop MD, Özdemir A, Akalın Çiftçi G, Ellakwa DE, Tateishi H, Radwan MO, Ibrahim MAA, Otsuka M, Fujita M, Ciftci HI, Ali TFS.
    Molecules; 2020 Nov 07; 25(21):. PubMed ID: 33171861
    [Abstract] [Full Text] [Related]

  • 23. Design, synthesis and docking study of novel picolinamide derivatives as anticancer agents and VEGFR-2 inhibitors.
    Zeidan MA, Mostafa AS, Gomaa RM, Abou-Zeid LA, El-Mesery M, El-Sayed MA, Selim KB.
    Eur J Med Chem; 2019 Apr 15; 168():315-329. PubMed ID: 30826508
    [Abstract] [Full Text] [Related]

  • 24. Novel 2-indolinone thiazole hybrids as sunitinib analogues: Design, synthesis, and potent VEGFR-2 inhibition with potential anti-renal cancer activity.
    Mahmoud HK, Farghaly TA, Abdulwahab HG, Al-Qurashi NT, Shaaban MR.
    Eur J Med Chem; 2020 Dec 15; 208():112752. PubMed ID: 32947227
    [Abstract] [Full Text] [Related]

  • 25. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
    Sherbiny FF, Bayoumi AH, El-Morsy AM, Sobhy M, Hagras M.
    Bioorg Chem; 2021 Nov 15; 116():105325. PubMed ID: 34507234
    [Abstract] [Full Text] [Related]

  • 26. Exploration of N-alkyl-2-[(4-oxo-3-(4-sulfamoylphenyl)-3,4-dihydroquinazolin-2-yl)thio]acetamide derivatives as anticancer and radiosensitizing agents.
    Soliman AM, Ghorab MM.
    Bioorg Chem; 2019 Jul 15; 88():102956. PubMed ID: 31054432
    [Abstract] [Full Text] [Related]

  • 27. Discovery of novel indolyl-1,2,4-triazole hybrids as potent vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors with potential anti-renal cancer activity.
    Al-Hussain SA, Farghaly TA, Zaki MEA, Abdulwahab HG, Al-Qurashi NT, Muhammad ZA.
    Bioorg Chem; 2020 Dec 15; 105():104330. PubMed ID: 33038552
    [Abstract] [Full Text] [Related]

  • 28. Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies.
    Parmar DR, Soni JY, Guduru R, Rayani RH, Kusurkar RV, Vala AG, Talukdar SN, Eissa IH, Metwaly AM, Khalil A, Zunjar V, Battula S.
    Bioorg Chem; 2021 Oct 15; 115():105206. PubMed ID: 34339975
    [Abstract] [Full Text] [Related]

  • 29. Design and synthesis of new 1,6-dihydropyrimidin-2-thio derivatives targeting VEGFR-2: Molecular docking and antiproliferative evaluation.
    Marzouk AA, Abdel-Aziz SA, Abdelrahman KS, Wanas AS, Gouda AM, Youssif BGM, Abdel-Aziz M.
    Bioorg Chem; 2020 Sep 15; 102():104090. PubMed ID: 32683176
    [Abstract] [Full Text] [Related]

  • 30. Design, synthesis and biological evaluation of novel 4-anilinoquinazoline derivatives as hypoxia-selective EGFR and VEGFR-2 dual inhibitors.
    Wei H, Duan Y, Gou W, Cui J, Ning H, Li D, Qin Y, Liu Q, Li Y.
    Eur J Med Chem; 2019 Nov 01; 181():111552. PubMed ID: 31387063
    [Abstract] [Full Text] [Related]

  • 31. 2-Anilinopyrimidine derivatives: Design, synthesis, in vitro anti-proliferative activity, EGFR and ARO inhibitory activity, cell cycle analysis and molecular docking study.
    AboulWafa OM, Daabees HMG, Badawi WA.
    Bioorg Chem; 2020 Jun 01; 99():103798. PubMed ID: 32247112
    [Abstract] [Full Text] [Related]

  • 32. Design, synthesis and biological evaluation of 4-aniline quinazoline derivatives conjugated with hydrogen sulfide (H2S) donors as potent EGFR inhibitors against L858R resistance mutation.
    Zheng YG, Zhang WQ, Meng L, Wu XQ, Zhang L, An L, Li CL, Gao CY, Xu L, Liu Y.
    Eur J Med Chem; 2020 Sep 15; 202():112522. PubMed ID: 32619886
    [Abstract] [Full Text] [Related]

  • 33. Synthesis, Anticancer Screening of Some Novel Trimethoxy Quinazolines and VEGFR2, EGFR Tyrosine Kinase Inhibitors Assay; Molecular Docking Studies.
    Altamimi AS, El-Azab AS, Abdelhamid SG, Alamri MA, Bayoumi AH, Alqahtani SM, Alabbas AB, Altharawi AI, Alossaimi MA, Mohamed MA.
    Molecules; 2021 May 18; 26(10):. PubMed ID: 34069962
    [Abstract] [Full Text] [Related]

  • 34. Design, synthesis and anticancer evaluation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as potent EGFRWT and EGFRT790M inhibitors and apoptosis inducers.
    Gaber AA, Bayoumi AH, El-Morsy AM, Sherbiny FF, Mehany ABM, Eissa IH.
    Bioorg Chem; 2018 Oct 18; 80():375-395. PubMed ID: 29986185
    [Abstract] [Full Text] [Related]

  • 35. Development of Isatin-Based Schiff Bases Targeting VEGFR-2 Inhibition: Synthesis, Characterization, Antiproliferative Properties, and QSAR Studies.
    Seliem IA, Panda SS, Girgis AS, Tran QL, Said MF, Bekheit MS, Abdelnaser A, Nasr S, Fayad W, Soliman AAF, Sakhuja R, Ibrahim TS, Abdel-Samii ZKM, Al-Mahmoudy AMM.
    ChemMedChem; 2022 Jul 05; 17(13):e202200164. PubMed ID: 35511203
    [Abstract] [Full Text] [Related]

  • 36. Discovery of Novel Potent VEGFR-2 Inhibitors Exerting Significant Antiproliferative Activity against Cancer Cell Lines.
    Zhang Y, Chen Y, Zhang D, Wang L, Lu T, Jiao Y.
    J Med Chem; 2018 Jan 11; 61(1):140-157. PubMed ID: 29189002
    [Abstract] [Full Text] [Related]

  • 37. Design and Discovery of Quinazoline- and Thiourea-Containing Sorafenib Analogs as EGFR and VEGFR-2 Dual TK Inhibitors.
    Sun S, Zhang J, Wang N, Kong X, Fu F, Wang H, Yao J.
    Molecules; 2017 Dec 23; 23(1):. PubMed ID: 29295519
    [Abstract] [Full Text] [Related]

  • 38. Design, synthesis and in silico insights of new 7,8-disubstituted-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione derivatives with potent anticancer and multi-kinase inhibitory activities.
    Mohamed AR, El Kerdawy AM, George RF, Georgey HH, Abdel Gawad NM.
    Bioorg Chem; 2021 Feb 23; 107():104569. PubMed ID: 33387732
    [Abstract] [Full Text] [Related]

  • 39. Novel piperazine-chalcone hybrids and related pyrazoline analogues targeting VEGFR-2 kinase; design, synthesis, molecular docking studies, and anticancer evaluation.
    Ahmed MF, Santali EY, El-Haggar R.
    J Enzyme Inhib Med Chem; 2021 Dec 23; 36(1):307-318. PubMed ID: 33349069
    [Abstract] [Full Text] [Related]

  • 40. Spiroindole-containing compounds bearing phosphonate group of potential Mpro-SARS-CoV-2 inhibitory properties.
    Bekheit MS, Panda SS, Kariuki BM, Mahmoud SH, Mostafa A, Girgis AS.
    Eur J Med Chem; 2023 Oct 05; 258():115563. PubMed ID: 37329713
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.